Boston Megan 4
4 · Benitec Biopharma Inc. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2025-11-18+200,000→ 200,000 totalExercise: $13.53Exp: 2035-11-18→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026.